Skip to main content
Erschienen in: Archives of Osteoporosis 1/2019

01.12.2019 | Original Article

Intensive screening for osteoporosis in patients with hip fracture

verfasst von: Anas Ould Si Amar, Lars Hyldstrup, Jette Nielsen, Henrik Palm, Jens-Erik Beck Jensen

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Summary

Opportunities to evaluate, treat, and prevent future osteoporotic fractures are often being overlooked, especially in patients with a prior osteoporotic fracture. We find that an intensive outreach osteoporosis investigation strategy can help increase the number of patients investigated and treated for osteoporosis following a hip fracture.

Purpose

Patients experiencing a hip fracture are subject to an increased risk of subsequent fractures. This suggests an urgent need to develop strategies that will allow a higher number of patients with fragility hip fractures to be investigated and treated for osteoporosis. In accordance, we developed a secondary osteoporosis prevention program and evaluated the results of the program.

Methods

In the study period, 1071 patients with a hip fracture were admitted to Hvidovre University Hospital. Eligible patients were offered an osteoporosis investigation program, which included a DXA-scan with vertebral fracture assessment and a medical consultation. The data retrieved from this program were registered and analyzed. The primary goal of the study was to describe the number of subjects, who completed the program, and to characterize the initiated osteoporosis treatment. Secondary outcomes evaluated were prevalence of DXA-verified osteoporosis, changes in T-score due to treatment, and 1-year mortality rate.

Results

In total, 557 patients were offered participation of which 333 patients completed the full program. Among these, 159 patients had DXA-verified osteoporosis and 192 patients were started treatment. This resulted in a significant higher T-score at the lumbar spine and femoral neck compared with subjects not treated. Additionally, we report a 1-year mortality rate of 27.7% among all patients with hip fracture.

Conclusion

We report that an intensive outreach osteoporosis investigation program can help increase the number of hip fracture patients being tested and treated for osteoporosis. Further, the initiation of treatment can significantly increase the T-score.
Fußnoten
1
Defined as a Hindsoe-test score < 5 [13]
 
Literatur
1.
Zurück zum Zitat Kanis JA et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57CrossRef Kanis JA et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57CrossRef
2.
Zurück zum Zitat Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10(10):592–602CrossRef Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10(10):592–602CrossRef
3.
Zurück zum Zitat Antonelli M, Einstadter D, Magrey M (2014) Screening and treatment of osteoporosis after hip fracture: comparison of sex and race. J Clin Densitom 17(4):479–483CrossRef Antonelli M, Einstadter D, Magrey M (2014) Screening and treatment of osteoporosis after hip fracture: comparison of sex and race. J Clin Densitom 17(4):479–483CrossRef
4.
Zurück zum Zitat Kim SC et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128(5):519–526 e1 CrossRef Kim SC et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128(5):519–526 e1 CrossRef
5.
Zurück zum Zitat Nguyen ET et al (2018) Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Osteoporos Int 29(8):1827–1832CrossRef Nguyen ET et al (2018) Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Osteoporos Int 29(8):1827–1832CrossRef
6.
Zurück zum Zitat Axelsson KF, Jacobsson R, Lund D, Lorentzon M (2016) Effectiveness of a minimal resource fracture liaison service. Osteoporos Int 27(11):3165–3175CrossRef Axelsson KF, Jacobsson R, Lund D, Lorentzon M (2016) Effectiveness of a minimal resource fracture liaison service. Osteoporos Int 27(11):3165–3175CrossRef
7.
Zurück zum Zitat Tei RMH et al (2019) OFELIA: prevalence of osteoporosis in fragility fracture patients. Calcif Tissue Int 104(1):102–114CrossRef Tei RMH et al (2019) OFELIA: prevalence of osteoporosis in fragility fracture patients. Calcif Tissue Int 104(1):102–114CrossRef
8.
Zurück zum Zitat Leslie WD, Adler RA, el-Hajj Fuleihan G, Hodsman AB, Kendler DL, McClung M, Miller PD, Watts NB, International Society for Clinical Densitometry (2006) Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom 9(1):22–30CrossRef Leslie WD, Adler RA, el-Hajj Fuleihan G, Hodsman AB, Kendler DL, McClung M, Miller PD, Watts NB, International Society for Clinical Densitometry (2006) Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom 9(1):22–30CrossRef
9.
Zurück zum Zitat Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN (2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 10:937–948PubMedPubMedCentral Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN (2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 10:937–948PubMedPubMedCentral
10.
Zurück zum Zitat Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef
11.
Zurück zum Zitat Egan M et al (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22(3):272–282CrossRef Egan M et al (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22(3):272–282CrossRef
12.
Zurück zum Zitat Ip TP, Leung J, Kung AW (2010) Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int 21(Suppl 4):S605–S614CrossRef Ip TP, Leung J, Kung AW (2010) Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int 21(Suppl 4):S605–S614CrossRef
13.
Zurück zum Zitat Kristensen M (2010) Hip fractures - functional assessments and factors influencing in-hospital outcome, a physiotherapeutic perspective. In: Department of Health Sciences, Division of Physiotherapy & Department of Physiotherapy and Orthopaedic Surgery, Hvidovre Hospital and Section of Surgical Pathophysiology, Rigshospitalet, Copenhagen, Denmark. Lund University, Sweden. p 46–47 Kristensen M (2010) Hip fractures - functional assessments and factors influencing in-hospital outcome, a physiotherapeutic perspective. In: Department of Health Sciences, Division of Physiotherapy & Department of Physiotherapy and Orthopaedic Surgery, Hvidovre Hospital and Section of Surgical Pathophysiology, Rigshospitalet, Copenhagen, Denmark. Lund University, Sweden. p 46–47
14.
Zurück zum Zitat Parker MJ, Palmer CR (1993) A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg (Br) 75(5):797–798CrossRef Parker MJ, Palmer CR (1993) A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg (Br) 75(5):797–798CrossRef
15.
Zurück zum Zitat Holm JP et al (2015) Hyponatremia, a risk factor for osteoporosis and fractures in women. Osteoporos Int 27(3):989–1001 Holm JP et al (2015) Hyponatremia, a risk factor for osteoporosis and fractures in women. Osteoporos Int 27(3):989–1001
16.
Zurück zum Zitat Kelly T (1990) Bone Mineral reference databases for American men and women (abstract). J Bone Miner Res 5(suppl1):249 Kelly T (1990) Bone Mineral reference databases for American men and women (abstract). J Bone Miner Res 5(suppl1):249
17.
Zurück zum Zitat Kanis JA et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24(11):2763–2764CrossRef Kanis JA et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24(11):2763–2764CrossRef
18.
Zurück zum Zitat Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650CrossRef Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650CrossRef
19.
Zurück zum Zitat Saad R, Beydoun M, Fuleihan GE (2019) Management of hip fractures at an academic center: challenges and opportunities. J Clin Densitom Saad R, Beydoun M, Fuleihan GE (2019) Management of hip fractures at an academic center: challenges and opportunities. J Clin Densitom
20.
Zurück zum Zitat Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20(2):299–307CrossRef Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20(2):299–307CrossRef
21.
Zurück zum Zitat Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J (2003) Underuse of osteoporosis medications in elderly patients with fractures. Am J Med 115(5):398–400CrossRef Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J (2003) Underuse of osteoporosis medications in elderly patients with fractures. Am J Med 115(5):398–400CrossRef
22.
Zurück zum Zitat Klop C et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int 26(7):1919–1928CrossRef Klop C et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int 26(7):1919–1928CrossRef
24.
Zurück zum Zitat Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97(19):1555–1562CrossRef Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97(19):1555–1562CrossRef
25.
Zurück zum Zitat Giammattei F, Giammattei J, Howland V (2009) Physician follow-up care for osteoporosis after fragility fractures. Phys Sportsmed 37(4):62–67CrossRef Giammattei F, Giammattei J, Howland V (2009) Physician follow-up care for osteoporosis after fragility fractures. Phys Sportsmed 37(4):62–67CrossRef
26.
Zurück zum Zitat Roy A, Heckman MG, O'Connor MI (2011) Optimizing screening for osteoporosis in patients with fragility hip fracture. Clin Orthop Relat Res 469(7):1925–1930CrossRef Roy A, Heckman MG, O'Connor MI (2011) Optimizing screening for osteoporosis in patients with fragility hip fracture. Clin Orthop Relat Res 469(7):1925–1930CrossRef
27.
Zurück zum Zitat Senay A et al (2019) Rationale, study design, and descriptive data of the lucky bone fracture liaison service. Arch Osteoporos 14(1):19CrossRef Senay A et al (2019) Rationale, study design, and descriptive data of the lucky bone fracture liaison service. Arch Osteoporos 14(1):19CrossRef
28.
Zurück zum Zitat Major G et al (2019) The costs of confronting osteoporosis: cost study of an Australian fracture liaison service. JBMR Plus 3(1):56–63CrossRef Major G et al (2019) The costs of confronting osteoporosis: cost study of an Australian fracture liaison service. JBMR Plus 3(1):56–63CrossRef
29.
Zurück zum Zitat Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, Aickin M, Swain MC (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54(3):450–457CrossRef Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, Aickin M, Swain MC (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54(3):450–457CrossRef
Metadaten
Titel
Intensive screening for osteoporosis in patients with hip fracture
verfasst von
Anas Ould Si Amar
Lars Hyldstrup
Jette Nielsen
Henrik Palm
Jens-Erik Beck Jensen
Publikationsdatum
01.12.2019
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2019
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-019-0612-3

Weitere Artikel der Ausgabe 1/2019

Archives of Osteoporosis 1/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.